Equities

Cyfuse Biomedical KK

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4892:TYO

Cyfuse Biomedical KK

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)655.00
  • Today's Change-22.00 / -3.25%
  • Shares traded79.80k
  • 1 Year change-26.32%
  • Beta--
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Tuesday, Cyfuse Biomedical KK (4892:TYO) closed at 655.00, 26.94% above the 52 week low of 516.00 set on Dec 15, 2025.
52-week range
Today
516.00Dec 15 20251,412.00Mar 03 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open671.00
High676.00
Low650.00
Bid648.00
Offer660.00
Previous close677.00
Average volume70.78k
Shares outstanding9.96m
Free float7.28m
P/E (TTM)--
Market cap6.75bn JPY
EPS (TTM)--
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.